Mitochondrial hepatopathy: Anticipated difficulties in management of fatty acid oxidation defects and urea cycle defects

doi:10.4254/wjh.v14.i1.180

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5844)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

349

WORD

HTML

4025

Figures (1-4)

401

Tables (1-1)

216

Sum=5086

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

263

Download

495

Sum=758

Jan 27, 2022 (publication date) through Jul 7, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Jan 27, 2022; 14(1): 180-194
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.180

Full Size Figure Download Figure

Figure 2 Beta-oxidation of fatty acids. CoA: Co-enzyme A; NAD: Nicotinamide adenine dinucleotide; NADH2: Nicotinamide adenine dinucleotide (reduced); FAD: Flavin adenine dinucleotide; FADH: Flavin adenine dinucleotide (reduced).

Citation: Ravindranath A, Sarma MS. Mitochondrial hepatopathy: Anticipated difficulties in management of fatty acid oxidation defects and urea cycle defects. World J Hepatol 2022; 14(1): 180-194
URL: https://www.wjgnet.com/1948-5182/full/v14/i1/180.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i1.180